MYACINTH PINEDA: Open Payments
NPI 1578152922 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 36 payments from 16 companies in 2025. Trend: 2023 $292 · 2024 $688 · 2025 $977
Food & beverage: $880Education: $97
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $194 |
| Travere Therapeutics, Inc. | 5 | $164 |
| Amgen Inc. | 5 | $148 |
| Veloxis Pharmaceuticals, Inc. | 2 | $117 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
| KYOWA KIRIN, INC. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: JARDIANCE, KRYSTEXXA, JYNARQUE, Fabhalta, PURIFIED CORTROPHIN GEL, CRYSVITA, BENLYSTA, ACTHAR.
Industry payments across NV — which companies pay providers there.
